Creative Enzymes, a global enzyme technology service provider, has launched an AI-integrated platform that systematically addresses the bottleneck in enzyme catalyst development for biomanufacturing. By merging computational enzyme engineering with hands-on process development, the platform delivers AI-Driven Biocatalysis Solutions that are predictable in silico and practical at industrial scale.
The gap between identifying biocatalysis opportunities and having suitable enzymes ready has long hindered iterative product development. Traditional approaches are too slow, but AI brings critical value by predicting enzyme candidates, designing enzymes constrained by process parameters, and leveraging molecular features to anticipate performance. This reduces the need for extensive experimental testing, saving R&D costs and minimizing process failure risk.
The platform offers three specialized service modules: AI-Driven Biocatalysis for end-to-end discovery and engineering, AI-Driven Industrial Biocatalysis to bridge lab-scale and commercial production, and AI-Driven Green Biocatalysis for sustainability-focused solutions. For moderately complex targets, the platform reduces the design-build-test-learn cycle from 12–24 months to 8–12 months.
A recent case study in transaminase engineering demonstrated the platform's capabilities. Researchers developed a 6D protein engineering framework combining interaction energy, solvent effects, and 1.39 million structural fragments to predict beneficial mutations. Five AI-selected transaminase variants, each with nine mutations, showed high solubility and stability at 7-liter fermentation scale, converting prochiral ketones to sitagliptin with over 99% enantiomeric purity and up to 89% conversion rates.
AI biocatalysis is making significant impacts in pharmaceuticals, particularly in asymmetric synthesis of chiral intermediates and replacing hazardous reagents. Agrochemicals and food industries are also adopting the technology to fine-tune toxicology profiles and deliver cleaner labels, while fine chemicals and personal care sectors explore high-value conversions and milder, more sustainable processes.
More details on the platform and its capabilities can be found on the Creative Enzymes website at https://www.creative-enzymes.com.
